Clinical Study Results

• GIOTRIF ® (afatinib) - Glioma

  Clinical Study Number	1200.38
  Study Indication	Glioma
  Product	GIOTRIF ® (afatinib)
  Generic Name	Afatinib
  Lab Code
  Clinical Phase	I
  Study Title	Phase I, open label trial to explore safety of combining BIBW 2992 and radiotherapy with or without temozolomide in newly diagnosed GBM
  Study Document	Lay summary 1200.38 english